Key Record Dates
ClinicalTrials.gov Identifier: | NCT06047197 |
---|---|
Brief Title: | Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma |
First Submitted : | September 1, 2023 |
First Submitted that Met QC Criteria : | September 14, 2023 |
First Posted : | September 21, 2023 |
Last Update Submitted that Met QC Criteria : | September 14, 2023 |
Last Update Posted : | September 21, 2023 |